ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Step Pharma raises funds through series B round to advance cancer drugs
March 26, 2021Biotech company Step Pharma has raised $41.3m (€35m) through the series B financing round to advance its lead cytidine triphosphate synthase 1 (CTPS1) inhibitor STP938 in the clinical development for treating T-cell malignancies. -
Step Pharma completes €14.5 million Series A financing
November 24, 2017CTPS1 is a novel target discovered at the Imagine Institute (Paris, France) in rare genetic disease patients exhibiting deficiency in this enzyme involved in CTP nucleotide production
Pharma Sources Insight January 2025
